Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
Lee M. Kaplan, Elena Startseva, Carel W. le Roux, Sean Wharton et autres